DANTROLENE Drug Patent Profile
✉ Email this page to a colleague
When do Dantrolene patents expire, and when can generic versions of Dantrolene launch?
Dantrolene is a drug marketed by Elite Labs Inc, Impax Labs, Eugia Pharma Speclts, and Hikma. and is included in four NDAs.
The generic ingredient in DANTROLENE is dantrolene sodium. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dantrolene
A generic version of DANTROLENE was approved as dantrolene sodium by IMPAX LABS on March 1st, 2005.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DANTROLENE?
- What are the global sales for DANTROLENE?
- What is Average Wholesale Price for DANTROLENE?
Summary for DANTROLENE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for DANTROLENE |
| DailyMed Link: | DANTROLENE at DailyMed |
US Patents and Regulatory Information for DANTROLENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Labs Inc | DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076686-001 | Oct 24, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Eugia Pharma Speclts | DANTROLENE SODIUM | dantrolene sodium | INJECTABLE;INJECTION | 205239-001 | Feb 18, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs | DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076856-001 | Mar 1, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | DANTROLENE SODIUM | dantrolene sodium | INJECTABLE;INJECTION | 204762-001 | Jun 19, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Elite Labs Inc | DANTROLENE SODIUM | dantrolene sodium | CAPSULE;ORAL | 076686-002 | Oct 24, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
